Literature DB >> 16887995

Homeostatic lymphoid chemokines synergize with adhesion ligands to trigger T and B lymphocyte chemokinesis.

Agnieszka N Stachowiak1, Yana Wang, Yen-Chen Huang, Darrell J Irvine.   

Abstract

Homeostatic chemokines such as CCL19, CCL21, and CXCL13 are known to elicit chemotaxis from naive T and B cells and play a critical role in lymphocyte homing to appropriate zones within secondary lymphoid organs (SLO). Here we tested whether CCL21 and CXCL13 modulate murine lymphocyte motility in the absence of concentration gradients, using videomicroscopy to directly observe the migration of single cells. CCL21 treatment of T cells induced rapid polarization and sustained random migration with average speeds of 5.16 +/- 2.08 microm/min; B cell migration (average velocity 4.10 +/- 1.58 microm/min) was similarly induced by CXCL13. Migration required the presence of both chemokine and adhesion ligands and was sustained for >24 h. Furthermore, in in vitro assays modeling the relative infrequency of Ag-specific T cell-dendritic cell (DC) encounters during primary immune responses, we found that CCL21 addition to T-DC cocultures accelerated the kinetics of CD69 up-regulation and enhanced by 2-fold the proliferation of Ag-specific T cells in a manner dependent on G-protein-coupled receptor signaling in T cells. These results suggest that homeostatic chemokines could substantially impact the dynamics and priming of lymphocytes within SLO even in the absence of significant concentration gradients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887995     DOI: 10.4049/jimmunol.177.4.2340

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Antibody to receptor activator of NF-κB ligand ameliorates T cell-mediated periodontal bone resorption.

Authors:  Xiaoping Lin; Xiaozhe Han; Toshihisa Kawai; Martin A Taubman
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes.

Authors:  Marc Bajénoff; Jackson G Egen; Lily Y Koo; Jean Pierre Laugier; Frédéric Brau; Nicolas Glaichenhaus; Ronald N Germain
Journal:  Immunity       Date:  2006-11-16       Impact factor: 31.745

Review 3.  Lymphocyte cell motility: the twisting, turning tale of phosphoinositide 3-kinase.

Authors:  J S Oak; M P Matheu; I Parker; M D Cahalan; D A Fruman
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

Review 4.  Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function.

Authors:  Christopher D C Allen; Jason G Cyster
Journal:  Semin Immunol       Date:  2008-02-07       Impact factor: 11.130

Review 5.  Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs.

Authors:  Michael D Cahalan; Ian Parker
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

6.  Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes.

Authors:  Koko Katagiri; Tomoya Katakai; Yukihiko Ebisuno; Yoshihiro Ueda; Takaharu Okada; Tatsuo Kinashi
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

7.  Linking morphodynamics and directional persistence of T lymphocyte migration.

Authors:  Xiaji Liu; Erik S Welf; Jason M Haugh
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

8.  How antigen quantity and quality determine T-cell decisions in lymphoid tissue.

Authors:  Huan Zheng; Bo Jin; Sarah E Henrickson; Alan S Perelson; Ulrich H von Andrian; Arup K Chakraborty
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

9.  Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.

Authors:  Ulrike Haessler; Marco Pisano; Mingming Wu; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

10.  In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy.

Authors:  Naozumi Ishimaru; Takeshi Nitta; Rieko Arakaki; Akiko Yamada; Martin Lipp; Yousuke Takahama; Yoshio Hayashi
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.